Our data also provide evidence for a genetic signature that affects striatal dopamine D2 receptor signaling and its relationship with WM prefrontal activity, a mechanism potentially involved in schizophrenia and other different brain disorders [4]. The gene discussed is DRD2; the disease is schizophrenia.